Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ali Zahed Mehr"'
Autor:
Mohammad Javad Alemzadeh-Ansari, Azin Alizadehasl, Ahmad Amin, Rasoul Azarfarin, Mitra Chitsazan, Bahram Fariborz Farsad, Amir Farjam Fazelifar, Ata Firouzi, Zahra Ghaemmaghami, Samad Ghaffari, Alireza Alizadeh Ghavidel, Majid Haghjoo, Saeid Hosseini, Zahra Hosseini, Farzad Kamali, Zahra Khajali, Reza Kiani, Majid Kyavar, Shabnam Madadi, Nejat Mahdieh, Hadi Malek, Alireza Maleki, Majid Maleki, Ali Zahed Mehr, Bahram Mohebbi, Hamid Mojibian, Jamal Moosavi, Nasim Naderi, Feridoun Noohi, Zeinab Norouzi, Hamidreza Pouraliakbar, Bahareh Rabbani, Hasan Allah Sadeghi, Parham Sadeghipour, Anita Sadeghpour, Sedigheh Saedi, Hanieh Salehi, Hamidreza Sanati, Omid Shafe, Farshad Shakerian, Samira Tabiban, Azita Haj Hossein Talasaz, Reza Yousefi-Nooraie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1abf8d93e56c6c21165589219da8fcea
https://doi.org/10.1016/b978-0-323-80915-3.09990-7
https://doi.org/10.1016/b978-0-323-80915-3.09990-7
Autor:
Ali Zahed Mehr, Hossein Shabaninejad, Nashmil Ghadimi, Alaadine Lijassi, Hossein Hosseinifard, Sara Kaveh
Publikováno v:
International journal of clinical pharmacy. 41(1)
Background Patients with mitral valve stenosis have increased heart rate. HR reduction is known as an important treatment and therapy strategy for patients with mitral valve stenosis. Aim of the review The aim of this systematic review and meta-analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a15f3815d1b029e58f19e314f9eaded
https://pubmed.ncbi.nlm.nih.gov/30659493
https://pubmed.ncbi.nlm.nih.gov/30659493
Autor:
Fanak Fahimi, Golshid Ghorbanian, Hooman Bakhshandeh, Zahra Ghaemmaghami, Bahram Fariborz Farsad, Ali Zahed Mehr, Seyed Mostafa Alavi
Publikováno v:
Journal of Renal Injury Prevention. 9:04-04
Introduction: Patients with diabetes mellitus (DM) have higher risk of coronary artery disease (CAD) and angina than the general population. Objectives: We sought to assess the impact of ranolazine as an antianginal agent to diminish hemoglobin A1c (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed27ed7fd6863ce2b14e291ae8873825
https://doi.org/10.15171/jrip.2020.04
https://doi.org/10.15171/jrip.2020.04
Autor:
Reza Kiani, Ata Firouzi, Hossein Shahsavari, Ali Zahed Mehr, Kamran Aeinfar, Farshad Shakerian, Hamid Reza Sanati
Publikováno v:
International Cardiovascular Research Journal, Vol 10, Iss 3, Pp 107-112 (2016)
Background: No-reflow phenomenon is a serious complication of primary Percutaneous Coronary Intervention (PCI), which may increase the risk of progressive myocardial damage, profound left ventricular dysfunction, and death. Objectives: This study aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ef5465be11cfca8893f96daec31c70
https://doi.org/10.17795/icrj-10(03)107
https://doi.org/10.17795/icrj-10(03)107